Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators and their colleagues.
How Virtual Primary Care Can Enrich Your Practice
Mike Battista, Director, Science & Research at Creyos The COVID-19 pandemic made the word “virtual” a part of our everyday lexicon. Many services that were